Media Coverage

According to a public filing Friday, Robert Kramer, CEO of Emergent BioSolutions, received a 51 percent increase in total compensation in 2020, to $5.6 million, before the company ruined 15 million doses of the Johnson & Johnson vaccine, according to The Washington Post. According to the report, the vaccine had been contaminated with ingredients of the AstraZeneca vaccine.

This limited series was created in honor of Supply & Demand Chain Executive magazine's 20-year anniversary. This professional development podcast includes interviews with supply chain students, young professionals, veterans, and professors who detail training, recruitment, retention, and the evolution of education in the supply chain.

Maryland health officials expect to see a drastic reduction in the state’s allocation of Johnson & Johnson’s COVID-19 vaccine next week — a shortfall that will lead to a 33% drop overall in the availability of first- or single-dose vaccines compared to this week, officials said.

COVID-19 exposed risks and spurred conversations about moving manufacturing, but the pandemic is far from the only factor to consider.

Yale SOM’s Vahideh Manshadi and Scott Rodilitz worked with Food Rescue US to hone their strategy for connecting volunteers with food donations. Their findings can help other nonprofits harness the power of crowds for social good.